Pulse pressure and systolic blood pressure are powerful independent predictors of cardiovascular disease in diabetic adults: Results of an 8.4 years follow-up of tehran lipid and glucose study (TLGS)

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 9, 2010, Pages 638-643

  Hadaegh, F ^a   Hatami, M ^a   Sheikholeslami, F ^a   Azizi, F ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

blood pressure; cardiovascular disease; diabetes

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SYSTOLE; TIME FACTORS;

EID: 77958149975     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1254085     Document Type: Article

References (40)

1. Agresti A. Building and Applying Logistic Regression Models: AN introduction to categorical Data Analysis. 2th ed. John Wiley &Sons, Inc, Hoboken, New Jersey 2007
2. Airaksinen KE, Salmela PI, Linnaluoto MK, et al. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993 27 942-945
3. Asia Pacific Cohort Studies Collaboration. Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region. Diabetologia 2007 50 2289-2297
4. Assmann G, Cullen P, Evers T, et al. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J 2005 26 2120-2126
5. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009 10 5
6. Azizi F, Rahmani M, Emami H, et al. Tehran Lipid and Glucose Study: rationale and design. CVD Prevention 2000 3 242-247
7. Cockcroft JR, Wilkinson IB, Evans M, et al. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens 2005 18 1463-1467 discussion 14681469
8. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007 115 928-935
9. Domanski M, Mitchell G, Pfeffer M, et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002 287 2677-2683
10. Domanski M, Norman J, Wolz M, et al. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001 38 793-797
11. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 1999 100 354-360
12. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001 103 1245-1249
13. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 3160-3167
14. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 19711993. Diabetes Care 1998 21 1138-1145
15. Hadaegh F, Bozorgmanesh MR, Ghasemi A, et al. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 2008 8 176
16. Hadaegh F, Harati H, Ghanbarian A, et al. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006 13 571-577
17. Hadaegh F, Harati H, Ghanbarian A, et al. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 2009a 15 157-166
18. Hadaegh F, Khalili D, Fahimfar N, et al. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 2009b 32 724-730
19. Hadaegh F, Khalili D, Ghasemi A, et al. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis 2009c 19 401-408
20. Haider DG, Mittermayer F, Friedl A, et al. Postprandial blood glucose level in maintenance hemodialysis patients predicts post-transplant-diabetes- mellitus. Exp Clin Endocrinol Diabetes 2010 118 200-204
21. Harati H, Hadaegh F, Saadat N, et al. Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009 9 186
22. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham study. Circulation 1980 61 1179-1182
23. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003 108 2543-2549
24. Mosley WJ, Greenland P, Garside DB, et al. Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension 2007 49 1256-1264
25. Nawroth PP, Rudofsky G, Humpert P. Have we understood diabetes? New tasks for diagnosis and therapy. Exp Clin Endocrinol Diabetes 2010 118 1-3
26. Nilsson PM, Cederholm J, Eeg-Olofsson K, et al. Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Diabetes Metab 2009 35 439-446
27. Pencina MJ, DAgostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statist Med 2004 23 2109-2123
28. Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 2001 161 1183-1192
29. Roger N. Parameters behind nonparametric statistic: Kendall's tau, SomersD and median differences. STATA J 2002 2 45-64
30. Safar ME. Pulse pressure, arterial stiffness, and cardiovascular risk. Curr Opin Cardiol 2000 15 258-263
31. Sanjari M, Hedayati M, Azizi F. Prevalence of Type 2 Diabetes Mellitus in 319 Age Group in East of Tehran in 2001. Irainian Juranal of Endocrinology & Metabolism 2007 9 119-126
32. Schram MT, Chaturvedi N, Fuller JH, et al. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study. J Hypertens 2003 21 2035-2044
33. Schram MT, Henry RM, van Dijk RA, et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 2004 43 176-181
34. Schram MT, Kostense PJ, Van Dijk RA, et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens 2002 20 1743-1751
35. Schram MT, Schalkwijk CG, Bootsma AH, et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 2005 46 232-237
36. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001 37 1053-1059
37. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008 51 527-539
38. Wilson PW, DAgostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 1837-1847
39. Wittek A, Sokalski B, Grzeszczak W, et al. Prevalence of diabetes and cardiovascular risk factors of industrial area in southern Poland. Exp Clin Endocrinol Diabetes 2009 117 350-353
40. Zabetian A, Hadaegh F, Azizi F. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Exp Clin Endocrinol Diabetes 2008 116 525-531